Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 [Phase 4]
Phase 4 study evaluating nintedanib for slowing lung disease in patients with fibrotic or non-fibrotic interstitial lung disease related to …
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma [Phase 2, Phase 3]
Phase 2/3 trials evaluated the efficacy and safety of oral bosentan for pulmonary fibrosis associated with systemic sclerosis, and the studi…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial of LASN01 in healthy subjects and patients with pulmonary fibrosis or thyroid eye disease has completed, assessin…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest [NA]
Completed Johns Hopkins trial evaluating oxygen delivery strategies. The study compares administered oxygen with high-flow ambient air at re…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of SC1011 in healthy subjects has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients [Phase 2]
Phase 2 trial update for BIO 300 oral suspension in previously hospitalized Long COVID patients; current status and results are not provided…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF [NA]
A completed clinical trial evaluating the impact of digital cognitive behavioral therapy (dCBT) on psychological symptom burden in adults wi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 [Phase 2]
A Phase 2 trial evaluating VL-PX10 plus VL-P22 for Pulmonary Fibrosis related to COVID-19 has been suspended.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Advancing Symptom Alleviation With Palliative Treatment [NA]
A completed clinical trial is reported evaluating palliative treatment for symptom relief in patients with heart failure and chronic lung di…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating pirfenidone (Esbriet) for pulmonary fibrosis associated with coal workers' pneumoconiosis; the study has…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Pulmonary Fibrosis After Severe COVID-19 Pneumonia
A completed clinical trial (NCT06423560) evaluating pulmonary fibrosis after severe COVID-19 pneumonia has finished.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19
A completed clinical trial evaluating Ga-68 FAPI PET/CT imaging to detect ongoing fibroblast activity in individuals recovering from COVID-1…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial evaluating nintedanib for SARS-CoV-2-induced pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Multiple Breath Washout as a Method for Diagnosing Lung Diseases
Completed clinical trial evaluating multiple breath washout as a diagnostic method for lung diseases, including pulmonary fibrosis, chronic …
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Colchicine and Post-COVID-19 Pulmonary Fibrosis [Phase 4]
A Phase 4 clinical trial update investigating colchicine for post-COVID-19 pulmonary fibrosis (interstitial pulmonary fibrosis).
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension [Phase 3]
Phase 3 trial of pulsed inhaled nitric oxide in subjects with pulmonary fibrosis at risk for pulmonary hypertension was terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab [Phase 2]
Phase 2 trial evaluating the efficiency of bevacizumab for pulmonary fibrosis induced by acute radiation and chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating pulsed inhaled nitric oxide for pulmonary hypertension associated with pulmonary fibrosis (pulmonary fibro…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis [Phase 2]
Phase 2 dose-escalation trial evaluating pulsed inhaled nitric oxide for safety and efficacy in pulmonary fibrosis and sarcoidosis (complete…
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia [Phase 2]
Phase 2 pilot study evaluating efficacy and safety of Treamid for rehabilitation after COVID-19 pneumonia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 [Phase 1, Phase 2]
Clinical trial update for MONACO cell therapy study evaluating monocytes as an anti-fibrotic treatment after COVID-19;Phase 1/Phase 2, spons…
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan
Non-interventional study collecting experiences for idiopathic pulmonary fibrosis in Taiwan has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients [Phase 1, Phase 2]
Early-phase trial exploring intramuscular polymerized type I collagen for modulation of cytokine storm in COVID-19 patients with inflammator…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19 [Phase 2]
Phase 2 trial update on nintedanib for pulmonary fibrosis in moderate to severe COVID-19 patients assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Supplemental Oxygen in Pulmonary Fibrosis
Clinical trial update on supplemental oxygen in pulmonary fibrosis has completed; results posted in 2020.